Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
Stock Snapshot
With a market cap of 121.1B, Bristol-Myers Squibb(BMY) trades at $59.34. The stock has a price-to-earnings ratio of 19.46 and currently yields dividends of 4.3%.
As of 2026-02-06, Bristol-Myers Squibb(BMY) stock has fluctuated between $57.37 and $60.56. The current price stands at $59.34, placing the stock +3.4% above today's low and -2.0% off the high.
The Bristol-Myers Squibb(BMY)'s current trading volume is 23.93M, compared to an average daily volume of 13.65M.
In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $63.33 and a 52-week low of $42.52.
In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $63.33 and a 52-week low of $42.52.
BMY News
Bristol-Myers Squibb Company ((BMY)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fun...
Srikripa Devarakonda, an analyst from Truist Financial, maintained the Buy rating on Bristol-Myers Squibb. The associated price target remains the same with $65...
Bristol Myers’ Growth Portfolio surged 16% to $7.4B in Q4 while Legacy Portfolio fell 15% on generic competition. Bristol Myers Squibb (BMY) guided 2026 revenu...
Analyst ratings
60%
of 30 ratingsMore BMY News
Bristol-Myers Squibb ( (BMY) ) has provided an update. On February 5, 2026, Bristol Myers Squibb reported its fourth-quarter and full-year 2025 financial resul...
(RTTNews) - While reporting financial results for the fourth quarter on Thursday, Bristol-Myers Squibb Co. (BMY) initiated its adjusted earnings and revenue gro...
Bristol-Myers Squibb (NYSE:BMY) has agreed to acquire Orbital Therapeutics to expand its RNA-based therapies portfolio for cancer and autoimmune diseases. The...
Bristol-Myers Squibb (NYSE:BMY) agreed to acquire Orbital Therapeutics, adding RNA-based therapies for cancer and autoimmune diseases to its pipeline. Lupin la...
Bristol-Myers Squibb, NYSE:BMY, has entered a collaboration with Janux Therapeutics to co-develop a tumor-activated cancer therapy targeting solid tumors. The...
Bristol-Myers Squibb Company (BMY), Biontech Se Sponsored Adr (BNTX) announced an update on their ongoing clinical study. Study Overview BioNTech and Bristol-...
Bristol-Myers Squibb (BMY) is back on many investors’ radar after recent share price moves and fresh scrutiny of its fundamentals, including revenue of US$48.0b...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.